News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

COVID test
By Walter Isaacson, STAT | 03.03.2021

In early January 2020, Feng Zhang, a gene-editing researcher at the Broad Institute of MIT and Harvard, started getting emails...

Robot arm
By Vivek Wadhwa, Tarun Wadhwa, Foreign Policy | 03.01.2021

A century’s worth of change is about to be squeezed into a single decade. By 2030, entire industries are likely...

By Alexandra Minna Stern, Los Angeles Times | 02.28.2021

Last month, Caltech announced that the names of six men with historical ties to the university would be removed from...

Voting hand
By Stephen Hilgartner, J. Benjamin Hurlbut, Sheila Jasanoff, Science | 02.26.2021

On 7 November 2020, moments before Kamala Harris and Joe Biden began their victory speeches, giant screens flanking the stage...

By J. Benjamin Hurlbut, MIT Technology Review | 02.24.2021

The conventional story of CRISPR genome editing is one of heroic power and promise with an element of peril. That...

Cover of CRISPR Journal
By Marcy Darnovsky, Katie Hasson, and Timothy M. Krahn, The CRISPR Journal | 02.19.2021

In response to: https://www.liebertpub.com/doi/10.1089/crispr.2021.29121.gle

Levrier apparently misunderstands the nature of our project published in The CRISPR Journal in October 2020...

Sickle cell anemia blood under microscope
By Elizabeth Cooney, STAT | 02.17.2021

Image licensed under the CC BY 3.0

Novartis and the Bill and Melinda Gates Foundation are joining forces to discover...

sickle cells
By Adam Feuerstein, STAT | 02.16.2021

Bluebird Bio said Tuesday that it has suspended clinical trials involving its gene therapy for sickle cell disease after receiving...